J. Queiruga-Parada

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial

A. Borobia, J. Marcos, A. Carcas, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

A. Borobia, C. Solano, A. Carcas, 2021, Trials.

Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

A. Borobia, C. Solano, A. Carcas, 2021, EClinicalMedicine.

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial

A. Borobia, A. Carcas, J. Arribas, 2022, Journal of clinical medicine.

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).

M. Díaz-Almirón, R. Goterris, R. de Paz, 2023, Cytotherapy.